| A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus AA Grolla, R Miggiano, D Di Marino, M Bianchi, A Gori, G Orsomando, ... Journal of Biological Chemistry 295 (11), 3635-3651, 2020 | 31 | 2020 |
| The cytokine nicotinamide phosphoribosyltransferase (eNAMPT; PBEF; visfatin) acts as a natural antagonist of CC chemokine receptor type 5 (CCR5) S Torretta, G Colombo, C Travelli, S Boumya, D Lim, AA Genazzani, ... Cells 9 (2), 496, 2020 | 28 | 2020 |
| Unsymmetric cisplatin-based Pt (IV) conjugates containing a PARP-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines E Gabano, G Pinton, C Balzano, S Boumya, D Osella, L Moro, M Ravera Molecules 26 (16), 4740, 2021 | 10 | 2021 |
| A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment S Boumya, S Fallarini, S Siragusa, G Petrarolo, S Aprile, V Audrito, ... International Journal of Molecular Sciences 24 (7), 6689, 2023 | 6 | 2023 |
| Epigenetic Insights on PARP-1 Activity in Cancer Therapy G Pinton, S Boumya, MR Ciriolo, F Ciccarone Cancers 15 (1), 6, 2022 | 3 | 2022 |
